"Farmagen Klinik Araştırma Merkezi, 2009 yılında kurularak Gaziantep Üniversitesi Teknoloji Geliştirme Bölgesi’nde hizmet vermeye başlamıştır. Klinik Merkez her iki yılda bir düzenli olarak Sağlık Bakanlığı İlaç ve Eczacılık Genel Müdürlüğü tarafından denetime ve sertifikasyona tabi tutulmaktadır. Merkezde Biyoyaralanım ve Biyoeşdeğerlik çalışmaları yürütülmektedir. Farmagen Klinik Araştırma Merkezi üç katlı olarak yaklaşık 1200 m2 alan üzerine inşa edilmiştir. Toplam 40 yatak kapasiteli iki klinik bulunmaktadır. Dinlenme ve yemek alanları, laboratuvar, arşiv, toplantı salonları, ilaç saklama odası, acil müdahale odası, kan alma, EKG ve muayene odaları merkezin diğer alanlarını oluşturmaktadır."

During the past decade, Farmagen Ar-Ge Biyot. Ltd. Sti. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Farmagen Ar-Ge Biyot. Ltd. Sti." #1 collaborator was "Farmagen Ar-Ge Biyot. Ltd. Sti" with 5 trials as a collaborator and "Novagenix Bioanalytical Drug R&D Center" with 5 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Farmagen Ar-Ge Biyot. Ltd. Sti." are "Bioequivalence" (5 trials). Many other conditions were trialed in "Farmagen Ar-Ge Biyot. Ltd. Sti." in a lesser frequency.

Most popular intervention types in "Farmagen Ar-Ge Biyot. Ltd. Sti." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "ARBIDOL 100 MG KAPSUL" (1 trials), "ATAFENOVIR 200 MG KAPSUL" (1 trials), "AVIGAN 200 MG Film Tablets" (1 trials), "AVIGAN 200 mg Film Tablets" (1 trials) and "FAVICOVIR 200 mg Film Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Farmagen Ar-Ge Biyot. Ltd. Sti." are 5 trials for "Male" genders.

Currently, there are NaN active trials in "Farmagen Ar-Ge Biyot. Ltd. Sti.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Farmagen Ar-Ge Biyot. Ltd. Sti., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Farmagen Ar-Ge Biyot. Ltd. Sti., 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".